| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
38,359,000 |
| Market
Cap: |
2.73(B) |
| Last
Volume: |
317,894 |
Avg
Vol: |
356,192 |
| 52
Week Range: |
$61.9 - $136.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 11.8 |
| Insider 6 Months : 11.8 |
| Insider 3/6 Months : 23.5 |
|
| Guru Rank Number : 918 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. Co.'s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. Co.'s orthopedic surgery product offering includes sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under several brands, including Hall®, CONMED Linvatec®, Concept® and Shutt®. Co.'s general surgery product line provides a range of products in the areas of surgical, endoscopic technologies and critical care.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
7,792 |
7,792 |
7,792 |
7,792 |
| Total Buy Value |
$544,055 |
$544,055 |
$544,055 |
$544,055 |
| Total People Bought |
4 |
4 |
4 |
4 |
| Total Buy Transactions |
4 |
4 |
4 |
4 |
| Total Shares Sold |
0 |
0 |
6,855 |
131,498 |
| Total Sell Value |
$0 |
$0 |
$742,096 |
$14,676,122 |
| Total People Sold |
0 |
0 |
2 |
9 |
| Total Sell Transactions |
0 |
0 |
4 |
20 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Farkas Charles |
Director |
• • – |
2016-01-04 |
4 |
AB |
$42.18 |
$14,005 |
D/D |
332 |
4,064 |
|
- |
|
| Berge Terence M |
VP Corp. Treasurer |
• • – |
2015-12-31 |
5 |
A |
$44.05 |
$1,404 |
I/I |
32 |
1,263 |
|
- |
|
| Peters Stanley W Iii |
VP GM Advanced Surgery |
• • – |
2015-12-31 |
4 |
A |
$41.85 |
$9,040 |
D/D |
216 |
401 |
|
- |
|
| Jonas Daniel |
EVP Legal Affairs,Gen. Counsel |
• • – |
2015-12-31 |
4 |
A |
$41.85 |
$4,018 |
D/D |
96 |
15,528 |
|
- |
|
| Bronson David M |
Director |
• • – |
2015-12-11 |
4 |
B |
$41.01 |
$61,522 |
D/D |
1,500 |
1,500 |
2.39 |
- |
|
| Snyder Mark D |
EVP Mfg. Ops & Business System |
• • – |
2015-11-23 |
4 |
D |
$42.36 |
$313,083 |
D/D |
(7,391) |
13,858 |
|
- |
|
| Snyder Mark D |
EVP Mfg. Ops & Business System |
• • – |
2015-11-23 |
4 |
OE |
$26.09 |
$273,220 |
D/D |
10,000 |
15,294 |
|
- |
|
| Kennedy John Jed |
VP GM CET |
• • – |
2015-10-26 |
4 |
D |
$40.24 |
$7,122 |
D/D |
(177) |
1,249 |
|
- |
|
| Kennedy John Jed |
VP GM CET |
• • – |
2015-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
560 |
1,426 |
|
- |
|
| Farkas Charles |
Director |
• • – |
2015-10-01 |
4 |
AB |
$47.24 |
$13,939 |
D/D |
292 |
3,732 |
|
- |
|
| Jones Gregory Renard |
EVP-Corporate QA/RA |
• • – |
2015-09-30 |
4 |
A |
$45.35 |
$4,444 |
D/D |
98 |
15,465 |
|
- |
|
| Peters Stanley W Iii |
VP GM Advanced Surgery |
• • – |
2015-09-30 |
4 |
A |
$45.35 |
$8,390 |
D/D |
185 |
185 |
|
- |
|
| Jonas Daniel |
EVP Legal Affairs,Gen. Counsel |
• • – |
2015-09-30 |
4 |
A |
$45.35 |
$4,036 |
D/D |
89 |
15,432 |
|
- |
|
| Jones Gregory Renard |
EVP-Corporate QA/RA |
• • – |
2015-08-11 |
4 |
S |
$56.03 |
$140,064 |
D/D |
(2,500) |
15,367 |
|
- |
|
| Hartman Curt R |
President & CEO |
• • – |
2015-08-06 |
4 |
B |
$55.93 |
$111,852 |
D/D |
2,000 |
22,529 |
2.74 |
- |
|
| Workman John L |
Director |
• • – |
2015-07-28 |
4 |
B |
$57.83 |
$115,659 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| Farkas Charles |
Director |
• • – |
2015-07-02 |
4 |
AB |
$58.66 |
$12,024 |
D/D |
205 |
3,440 |
|
- |
|
| Jones Gregory Renard |
EVP-Corporate QA/RA |
• • – |
2015-06-30 |
4 |
A |
$55.36 |
$4,373 |
D/D |
79 |
17,867 |
|
- |
|
| Jonas Daniel |
EVP Legal Affairs,Gen. Counsel |
• • – |
2015-06-30 |
4 |
A |
$55.36 |
$3,986 |
D/D |
72 |
15,343 |
|
- |
|
| Golden Jo Ann |
Director |
• • – |
2015-06-12 |
4 |
S |
$56.00 |
$56,031 |
D/D |
(1,000) |
17,043 |
|
- |
|
| Golden Jo Ann |
Director |
• • – |
2015-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
18,043 |
|
- |
|
| Tryniski Mark E |
Director |
• • – |
2015-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
19,000 |
|
- |
|
| Snyder Mark D |
EVP Mfg. Operations & Supply |
• • – |
2015-06-01 |
4 |
D |
$55.70 |
$63,220 |
D/D |
(1,135) |
11,249 |
|
- |
|
| Snyder Mark D |
EVP Mfg. Operations & Supply |
• • – |
2015-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,280 |
11,387 |
|
- |
|
| Pomilio Luke A |
EVP, Finance & CFO |
• • – |
2015-06-01 |
4 |
D |
$55.70 |
$121,705 |
D/D |
(2,185) |
28,323 |
|
- |
|
1826 Records found
|
|
Page 27 of 74 |
|
|
1.73 (2.38%) 
